Cisplatin-induced changes in biological activity of blood platelets: Thiol-related mechanisms

Anti-Cancer Drugs

Volumn 7, Issue 4, 1996, Pages 476-482

  Olas, Beata ^a   Wachowlcz, Barbara ^a  

^a UNIVERSITY OF LODZ   (Poland)

Author keywords

Blood platelet; Cisplatin; Glutathione; Transplatin

Indexed keywords

ADENOSINE DIPHOSPHATE; CISPLATIN; GLUTATHIONE; OXYGEN RADICAL; PLATINUM COMPLEX; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THIOL; TRANSPLATIN;

ANIMAL CELL; ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; COMPLEX FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DOSE TIME EFFECT RELATION; DRUG ACTIVITY; DRUG MECHANISM; LIPID PEROXIDATION; NONHUMAN; PRIORITY JOURNAL; SWINE; THROMBOCYTE AGGREGATION;

ANIMALS; ANTINEOPLASTIC AGENTS; ARACHIDONIC ACID; BLOOD PLATELETS; CISPLATIN; GLUTATHIONE; PLATELET ACTIVATION; SULFHYDRYL COMPOUNDS; SWINE;

EID: 0029934118     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199606000-00013     Document Type: Article

References (40)

1. Honn KV, Dean G, Tang MD, Chen YQ. Platelets and cancer metastasis: more than an epiphenomenon. Semin Thrombosis Hemostasis 1992; 4: 392-415.
2. Gasic GJ, Gasic TB. Removal of sialic acid from the cell coat in tumor cells and vascular endothelium and its effects on metastasis. Proc Natl Acad Sci USA 1962; 48: 1172-77.
3. Gasic G, Gasic T, Stewart CC. Anti-metastatic effects associated with platelet reduction. Proc Natl Acad Sci USA 1968; 61: 46-56.
4. Bastida E, Almirall L, Ordinas B. Tumor-cell-induced platelet aggregation is a glycoprotein dependent and lipoxygenase associated process. Int J Cancer 1987; 39: 760-63.
5. De Groot PG, Sixma JJ. Platelet adhesion. Br J Haematol 1990; 75: 308-12.
6. 3 and cytoskeleton in tumor cell-platelet interaction? Clin Exp Metastasis 1992; 10: 125-37.
7. Gasic GJ. Role of plasma, platelets, and endothelial cells in tumor metastasis. Cancer Metastasis Rev 1984; 3: 99-116.
8. Jamieson GA, Bastida E, Ordinas A. Interaction of platelets and tumor cells. In: MacIntyre G, ed. Platelets in biology and pathology III. Elsevier: Amsterdam 1987: 161-87.
9. Barnard CFJ. Platinum anti-cancer agents, twenty years of continuing development. Platinum Metals Rev 1989; 33: 162-7.
10. Maines MD. Effect of cis-platinum on heme, drug, and steroid metabolism patways: possible involvement in nephrotoxicity and infertility. Toxicology 1990; 21: 1-20.
11. Walter Z, Spychala M. The effect of cis-diamminedichloroplatinum(II) on the formation of DNA-Pt-DNA crosslinks. Acta Biochim Pol 1991; 38: 95-9.
12. 195mPt-radiolabelled cis-diaminedichloroplatinum(II). Int J Radiat Biol 1994; 66: 215-20.
13. Chen G, Waxman D. Role of cellular glutathione and glutathione S-transferase in the expression of alkylating agent cytotoxicity in human breast cancer cells. Biochem Pharmacol 1994; 47: 1079-87.
14. Odenhaimer B, Wolf W. Reactions of cisplatin with sulfur containing amino acids and peptides. Inorgan Chim Acta 1982; 66: 41-3.
15. Meijer C, Mulder NH, Hospers GAP, et al The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line. Br J Cancer 1990; 62: 72-7.
16. Ishikawa T, Ali-Osman F. Glutathione-associated cis-diamminedichloroplatinum(II) metabolism and ATP dependent efflux from leukemia cells. J Biol Chem 1993; 27: 20116-25.
17. Awasthi S, Sharma R, Singal SS, et al. Modulation of cisplatin cytotoxicity by sulphasaline. Br J Cancer 1994; 70: 190-4.
18. Wachowicz B. Effect of cisplatin on lipid peroxidation in blood platelets. Acta Biochim Pol 1991; 38: 87-90.
19. Wachowicz B, Kustron J. Effect of cisplatin on lipid peroxidation in pig blood platelets. Cytobios 1992; 70: 41-7.
20. Wachowicz B, Szwarocka A. Responce of pig blood platelets to cisplatin and sodium selenite: lipid peroxidation and oxygen radical generation. Biomed Lett 1994; 49: 147.
21. Wachowicz B. Inhibitory effect of cisplatin on the enzymatic peroxidation of platelet endogenous arachidonate. Cytobios 1993; 75: 57-162.
22. Vatassery GT, Smith WE. Determination of α-tocopherolquinone (vitamin E quinone) in human serum, platelets, and red cell membrane samples. Anal Biochem 1987; 167: 411-7.
23. Ando Y, Steiner M. Sulfhydryl and disulfide groups of platelet membranes: determination of disulfide groups. Biochim Biophys Acta 1973; 311: 26-37.
24. Ando Y, Steiner M. Sulfhydryl and disulfide groups of platelet membranes: determination of sulfhydryl groups. Biochim Biophys Acta 1973; 311: 38-44.
25. Wachowicz B. Adenine nucleotides in thrombocytes of birds. Cell Biochem Function 1984; 2: 167-70.
26. Jahn B, Hansch C. Oxygen radical generation in human platelets: dependence on 12-lipoxygenase activity and on the glutathione cycle. Int Arch Allergy Appl Immunol 1990; 93: 73-9.
27. Weiss RB, Christian MC. New cisplatin analogues in development. Drugs 1993; 46: 360-77.
28. Muggia FM, Los G. Platinum resistance: laboratory findings and clinical implications. Stem Cells 1993; 11: 182-93.
29. Ohno S, Strebel FR, Stephens LC, et al. Haematological toxicity of carboplatin and cisplatin combined with whole body hyperthermia in rats. Br J Cancer 1993; 68: 469-74.
30. Akaboshi M, Kawai K, Maki H, et al. Determination of the target volume of HeLa cells treated with tetra- and hexa-chloroplatines. Toxicol Environ Chem 1993; 39: 51-60.
31. Pendyala L, Creaven PJ. In vitro cytotoxicity, protein binding, red blood cell partitioning, and biotransformation of oxaliplatin. Cancer Res 1993; 53: 5970-6.
32. Spitz DR, Phillips JW, Adams DT, et al. Cellular resistance to oxidative stress is accompanied by resistance to cis-platin: the significance of increased catalase activity and total glutathione in hydrogen peroxide-resistant fibroblasts. J Cell Physiol 1993; 156: 72-9.
33. Hanigan MH, Gallagher BC, Taylor PT, et al. Inhibition of γ-glutamyl transpeptidase activity by acivicin in vivo protects the kidney from cisplatin-induced toxicity. Cancer Res 1994; 54: 5925-9.
34. Hamers FPT, Brakkee JH, Cavelleti F, et al. Reduced glutathione protects against cisplatin induced neurotoxicity in rats. Cancer Res 1993; 53: 544-9.
35. Litterst CK, Tang S, Hirata Y, et al. Alterations in hepatic and renal levels of glutathione and activities of glutathione S-transferases from rats treated with cis-dichlorodiammineplatinum (II). Cancer Chemother Pharmacol 1982; 8: 67-1.
36. Jones MM, Basinger MA. Thiol and thioether suppression of cis-platinum-induced nephrotoxicity in rats bearing the Walker 256 carcinosarcoma. Anticancer Res 1989; 9: 1937-42.
37. Leone R Fracasso MF, Soresi E, et al. Influence of glutathione administration on the disposition of free and total platinum in patients after administration of cisplatin. Cancer Chemother Pharmacol 1992; 29: 385-90.
38. Siemann DW, Beyers KL. In vivo therapeutic potential of combination thiol depletion and alkylating chemotherapy. Hr J Cancer 1993; 68: 1071-9.
39. Richardson ME, Dietmar MS, Siemann W. Thiol-related mechanisms of resistance in a murine tumor model. Int J Radiat Oncol Biol Phys 1994; 29: 387-92.
40. Wachowicz B, Krajewski T, Olas B, et al. Effect of cis-platin and selenite on the level of thiols in pig blood platelets. J Physiol Pharmacol 1995; 46: 97-103.